恶性贫血

恶性贫血与HLA-A、B抗原关联的研究

Studies on the Correlation of Pernicious anemia with HLA-A and-B

结论贲门癌患者存在恶性贫血倾向及慢性DIC发展过程。

Conclusion Pernicious anemia and chronic DIC process are found in patients with cardiac cancer .

人的恶性贫血是由于不能吸收维生素B12的结果。

Pernicious anemia in human is due to failure of absorption of vitamin B12 .

其它研究已经把维生素B12缺乏与恶性贫血，心血管疾病，癌症和神经再生紊乱联系起来了。

Other studies have linked B12 deficiency with pernicious anemia , cardiovascular disease , cancer , and neurodegenerative disorders .

其它如Addison病或恶性贫血等自身免疫疾病也可能出现。

Other autoimmune diseases such as Addison 's disease or pernicious anemia may also be present .

恶性贫血是胃炎的另一症状。

Another association with gastritis is pernicious anemia .

一种恶性贫血血液中各种成分发生变化。

Pernicious anemia in which the various formed elements in the blood are changed .

恶性贫血，有巨卵形红细胞、多叶核嗜中性粒细胞。

This hypersegmented neutrophil is present along with macro-ovalocytes in a case of pernicious anemia .

科技史上罕见的巧合&用生牛肝治愈恶性贫血而获诺贝尔奖的故事

Rarest Coincidence in the History of Science and Technology : Treatment of Pernicious Anemia by Uncooked Bovine Liver

众所周知A型萎缩性胃炎患者因胃IF缺乏可引起恶性贫血，但有关血清IF水平与胃粘膜功能状态的研究报道不多。

Reports that reflected the correlation between the level of serum IF and gastric mucosal functional status is few .

一种检测内因子抗体的实验方法被设计用于帮助诊断恶性贫血。

A test for intrinsic factor antibodies ( Ab ) is designed to aid the diagnosis of pernicious anemia .

持续性胃炎；可能是胃溃疡，恶性贫血，胃癌或其他失调的症状。

Persistent gastritis can be a symptom of a gastric ulcer or pernicious anemia or stomach cancer or other disorders .

结论：在恶性肿瘤贫血患者中使用rhEPO大剂量冲击维持疗法，可有效快速提高患者的血红蛋白水平，改善患者的贫血状况，该疗法耐受性较好，值得进一步扩大临床研究。

CONCLUSION : Induction therapy followed by maintenance with rhEPO can improve the level of hemoglobin significantly and quickly in anemic cancer patients .

目的测定恶性肿瘤贫血、缺铁性贫血STfR值，为恶性肿瘤贫血复合缺铁提供诊断依据。

Objective To measure serum transferrin receptor ( STfR ) in anemia of malignancy concurrent iron deficiency for offer diagnosis basis in anemia of malignancy concurrent iron deficiency .

恶性肿瘤贫血患者红细胞体积分布宽度检测探讨

Detection of Red Blood Cell Volume Distribution Width of Malignant Anemia Patients

结论恶性肿瘤贫血中有较多存在复合缺铁状况。

Conclusion Many anemia of malignancy have concurrent iron deficiency .

46例恶性肿瘤贫血患者外周血象的检测与分析

Detection and Analysis of Peripheral Hemogram of 46 Cases Malignant Anemic Patients

红细胞生成素治疗恶性肿瘤贫血的疗效观察

The effect of erythropoietin in treating the malignant tumour anemia

骨髓红系细胞凋亡、增殖及促红细胞生成素受体表达在恶性淋巴瘤贫血中的意义

Significance of apoptosis , proliferation and erythropoietin receptor expression on bone marrow erythroid cells in anemia associated with lymphoma

方法以化学发光法测定恶性肿瘤贫血病人及对照组血清铁蛋白水平。

Methods SF levels were detected with chemiluminescent technique , in the elderly malignant tumor patients with anemia and normal controls .

结果32例恶性肿瘤贫血中显示22例骨髓可染铁缺乏，占68.8%。

Results It was 68.8 % ( 22 / 32 ) for staining iron deficiency of bone marrow in anemia of malignancy .

结论rHuEPO是治疗恶性肿瘤相关贫血的有效药物。

Conclusions The rHuEPO is an effective drug in the treatment of anemia associated with malignancy .

促红细胞生成素在治疗恶性血液病贫血中应用

Application of Erythropoietin in Management of Anemia in Malignancy Hematologic Disease

目的：探讨促红细胞生成素在治疗恶性血液病患者贫血中的临床应用。

Objective : To approach clinical application of erythropoietin in management of anemia in malignancy hematologic disease .

排除严重肝肾功能不全、营养不良、严重恶性疾病（如恶性肿瘤）、恶性贫血、糖尿病病人。

The following conditions were excluded : severe hepatic and renal dysfunction , malnutrition , malignant tumour , malignant anemia , diabetes .